Biologically Active Small Molecules

A potential metabolite of fluprostenol when administered to animals a common minor impurity found in commercial preparations of the bulk drug compound.

A potential metabolite of fluprostenol when administered to animals a common minor impurity found in commercial preparations of the bulk drug compound.

A potential metabolite of fluprostenol when administered to animals a common minor impurity found in commercial preparations of the bulk drug compound.

The C-15 oxidized derivative of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin).

The C-15 oxidized derivative of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin).

The C-15 oxidized derivative of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin).

The C-15 oxidized derivative of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin).

A potential metabolite of latanoprost when administered to animals common minor impurity found in commercial preparations of the bulk drug compound.

A potential metabolite of latanoprost when administered to animals common minor impurity found in commercial preparations of the bulk drug compound.

A potential metabolite of latanoprost when administered to animals common minor impurity found in commercial preparations of the bulk drug compound.

A potential metabolite of latanoprost when administered to animals.

A potential metabolite of latanoprost when administered to animals.